Jun
9
Fri
SCCR Virtual Science Series: The Stanford experience: Pioneering the clinical treatment of mixed hematopoietic chimerism to induce transplantation tolerance @ Zoom Meeting Link
Jun 9 @ 9:00 am – 11:00 am
SCCR Virtual Science Series: The Stanford experience:  Pioneering the clinical treatment of mixed hematopoietic chimerism to induce transplantation tolerance @ Zoom Meeting Link


Speakers: Dr. Everett Meyer, MD, PhD, and Dr. Stephan Busque, MD

Click HERE to Register!

Zoom Class Link

The mission of the Stanford Center for Clinical Research (SCCR) includes offering educational resources, training, and support for investigators and research staff.  We have invited the Associate Professor of Medicine, BMT and Cell Therapy, Dr. Everett Meyer, MD, PhD, and the Professor of Surgery and Abdominal Transplantation, Dr. Stephan Busque, MD, to provide you with the Stanford Experience on the Cell Immune Therapy Tolerance, and discuss a patient experience as CIT trial participant. The speakers will review the genesis and development of the “Strober Protocol” where kidney transplant patients also get a minimally intensive allogeneic hematopoietic transplant from their patient. They will review how clinical trial conduct has been implemented and developed.

At the conclusion of this class, you will be able to:

  • Explain the biology and science of how mixed hematopoietic chimerism induces immune tolerance.
  • Review two decades of clinical trial results testing kidney and hematopoietic stem cell transplantation at Stanford.
  • Understand clinical trial conduct and successes and challenges of these trial.
  • Discuss patient experience being a trial participant.

Attendance is open to all research staff.

About the Presenters:

Dr. Everett Meyer, MD, PhD, MS, is an Associate Professor in the division of Blood and Marrow Transplantation and Cellular Therapy, with courtesy appointments in Surgery and Pediatrics. He has a focus on the pre-clinical and clinical study of immune tolerance. He serves as director of the Cellular Immune Tolerance program supported by DOM and Surgery and which receives critical clinical trial support from SCCR. His scientific focus is the study of hematopoietic chimerism and T regulatory cell therapy.
Dr. Stephan Busque, MD, is a Professor in the division of Abdominal Transplantation Surgery. He serves as Director Adult Kidney and Pancreas Transplant Program and Surgical Director of the Cellular Immune Tolerance Program and is widely regarded as a leading expert in the clinical implementation of immune tolerance in kidney transplantation. His research interest is focused on the improvement of clinical immunosuppression. He is involved in the evaluation of new immunosuppressive drugs, potentially more efficacious or less toxic, with the ultimate goal to achieve tolerance.

BRN OPTIONAL 

Spectrum is an approved provider by the California Board of Registered Nursing, Provider Number CEP15435 for 2 contact hour(s).
To receive your certificate with BRN credit, you are required to complete an evaluation at the conclusion of this class.
BRN Cancellation Policy: If you wish to cancel your registration, please contact the course coordinators, Susan Saba, ssaba@stanford.edu.